PCT Ltd

PCT Ltd, through its subsidiary, Paradigm Convergence Technologies Corporation, provides cleaning, sanitizing, and disinfectant fluid solutions and fluid-generating equipment worldwide. The company offers Hydrolyte, a sanitizer/disinfectant microbiocide for use in institutional facilities, including hospitals, nursing homes, hotels, correctional facilities, and schools; agriculture industry for pre- and post-harvest disinfection of crops, sanitization in food processing, and applications in animal husbandry; oil and gas industry to disinfect water and to kill sulfate reducing bacteria in oil and gas wells; and disinfecting and sanitizing water in public and private water systems and industrial waste-water systems. It also provides Catholyte, a mild detergent, degreaser, and surfactant that is used for janitorial cleaning purposes. The company was formerly known as Bingham Canyon Corporation and changed its name to PCT LTD in February 2018. PCT Ltd was incorporated in 1986 and is headquartered in Little River, South Carolina.

PCT Ltd trades as PCTL on OTC. The company is classified in Industrials / Industrial - Pollution & Treatment Controls and reports in USD.

The current profile places the business in Industrial - Pollution & Treatment Controls. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $1.27M of revenue and -$188,537 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

PCT Ltd can be compared against peers such as Deep Green Waste & Recycling, Inc., Digital Locations, Inc., Element Global, Inc., Firemans Contractors, Inc., Montague International Holding Ltd., Messaben Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $81,300, beta of 0.05, and return on equity of +7.6%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

PCTL currently shows total debt of $0 and beta of 0.05. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 8-K (2024-10-29 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.pctl.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.